PBMs Inflate Drug Costs, “Squeeze” Independent Pharmacies, FTC Says
- July 12, 2024
The vertically integrated and highly concentrated market structure of pharmacy benefit managers (PBMs) allows them to profit at the expense of patients and independent pharmacists, according to an interim report that the Federal Trade Commission (FTC) issued July 9.
ARTICLE TAGS
You must be logged in to access this content.